Advanced Biomedical Technologies, Inc.
ABMTOTCHealthcare● Active
$0.00
+$0.00(+0.00%)
Market Cap$50000
P/E Ratio—
52W High$0.0005
52W Low$0.0001
Advanced Biomedical Technologies, Inc.（ABMT）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · ABMT · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2022-10 | 2021-10 | 2020-10 | 2019-10 | 2018-10 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $0.27M | $0.17M | $0.12M | $0.01M | $0.00M |
| Cost of Revenue | $0.05M | $0.08M | $0.05M | $0.01M | $0.00M |
| Gross Profit | $0.22M | $0.09M | $0.07M | $0.00M | $0.00M |
| Gross Margin %(computed) | 81.88% | 54.50% | 58.07% | 34.84% | — |
| Operating Expenses | |||||
| R&D Expenses | $0.19M | $0.23M | $0.18M | $0.26M | $0.06M |
| G&A Expenses | $0.00M | $0.00M | $0.28M | $0.32M | $0.56M |
| Total Operating Expenses | $0.40M | $0.49M | $0.52M | $0.61M | $0.63M |
| Operating Income | ($0.18M) | ($0.39M) | ($0.45M) | ($0.60M) | ($0.63M) |
| Operating Margin %(computed) | -66.38% | -230.65% | -361.38% | — | — |
| Interest Income | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.33M | $0.32M | $0.33M | $0.33M | $0.30M |
| Income Before Tax | ($0.52M) | ($0.73M) | ($0.67M) | ($0.95M) | ($0.95M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($0.52M) | ($0.73M) | ($0.67M) | ($0.95M) | ($0.95M) |
| Net Margin %(computed) | -190.22% | -426.10% | -543.75% | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.01 | $-0.01 | $-0.01 | $-0.01 | $-0.01 |
| Wtd Avg Shares | 70.61M | 70.24M | 69.94M | 69.63M | 69.38M |
| EBITDA | ($0.17M) | ($0.37M) | ($0.28M) | ($0.60M) | ($0.64M) |
| EBITDA Margin %(computed) | -61.26% | -214.63% | -228.74% | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Advanced Biomedical Technologies, Inc.
关于Advanced Biomedical Technologies, Inc.（ABMT）损益表
Advanced Biomedical Technologies, Inc.（ABMT）损益表数据来源于SEC Form 10-K及10-Q申报文件。2022财年，ABMT实现营收$0.00B，毛利润$0.00B（毛利率81.88%），净利润($0.00B)（净利率-190.22%）。
常见问题
ABMT · 4 问Advanced Biomedical Technologies, Inc.（ABMT）2022财年营收为$0.00B，同比up58.3%。
ABMT revenueABMT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09